Exhibit 107.1
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Avenue Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule(1) | Amount Registered(2) | Proposed Maximum Offering Price Per Unit(1) | Maximum Aggregate Offering Price(1) | Fee Rate | Amount
of Registration Fee | ||||||||||||||||
| Equity | Common Stock, par value $0.0001 per share | 457(c) | 1,108,270 | (3) | $ | 1.16 | (2) | $ | 1,285,593.20 | .00011020 | $ | 141.67 | |||||||||||
| Total Offering Amounts | $ | 1,285,593.20 | $ | 141.67 | |||||||||||||||||||
| Total Fee Offsets | — | ||||||||||||||||||||||
| Net Fee Due | $ | 141.67 | |||||||||||||||||||||
(1) Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is the average of the high and low prices reported for the registrant’s Common Stock quoted on The Nasdaq Capital Market LLC on June 15, 2023.
(2) Pursuant to Rule 416(a) under the Securities Act, this registration statement also covers an indeterminate number of additional shares as may be issuable as a result of stock splits, stock dividends or similar transactions.
(3) Includes 276,652 shares of common stock of Avenue Therapeutics, Inc. that may be issued to a certain selling stockholder upon the achievement of a certain clinical development milestone.